Center for Advanced Preclinical Research: Collaborators and Partners
National Institutes of Health
The NIH’s National Center for Advancing Translational Sciences (NCATS) was established to transform the translational process so that new treatments and cures for disease can be delivered to patients faster.
MD Anderson Cancer Center is one of the largest cancer centers in the world. One of their greatest strengths is their ability to translate today’s most promising laboratory findings into tomorrow’s new, more effective, and less traumatic treatments.
Institute for Systems Biology (ISB) is a nonprofit biomedical research organization that pioneered the systems biology approach, which embraces biological complexity and fearlessly set about deciphering vast amounts of data in order to gain valuable insights and achieve breakthroughs across scientific disciplines.
University of California San Francisco (UCSF) is a leading institution dedicated exclusively to the health sciences. USCF’s dedicated scientists, clinicians, students and staff share a common drive to make the world a better place by advancing health and the human condition.
Cancer Research UK funds scientists, doctors and nurses to help beat cancer sooner. Over the past century, their researchers have made consistent progress in the fight against cancer and survival has doubled over the past 40 years.
Clovis Oncology is a biopharmaceutical company that is developing targeted therapies in combination with companion diagnostics to better serve patients and ensure that the right drug gets to the right patient.
AbbVie is a global biopharmaceutical company that combines advanced science, expertise and passion to solve serious health issues and have a remarkable impact on people’s lives.
MedImmune is a biotechnology company focused on therapeutic proteins, monoclonal antibodies and other next-generation molecules to attack a range of diseases.
SolaranRx is developing a new class of therapies and companion imaging agents to treat metastatic melanoma.
Cure Pancreatic Cancer-Lustgarten Foundation is a not-for-profit organization created in 1998 to advance the science related to the diagnosis, treatment, cure and prevention of pancreatic cancer.
Noble Life Sciences is a preclinical contract research organization offering standard GLP and non-GLP services, including safety and efficacy testing, for the development of drugs, vaccines, and medical devices.